Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1
Open Access
- 28 December 2009
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 207 (1), 7-16
- https://doi.org/10.1084/jem.20091508
Abstract
Multiple sclerosis and its preclinical model, experimental autoimmune encephalomyelitis, are marked by perivascular inflammation and demyelination. Myeloid cells, derived from circulating progenitors, are a prominent component of the inflammatory infiltrate and are believed to directly contribute to demyelination and axonal damage. How the cytotoxic activity of these myeloid cells is regulated is poorly understood. We identify CMRF-35–like molecule-1 (CLM-1) as a negative regulator of autoimmune demyelination. CLM-1 is expressed on inflammatory myeloid cells present in demyelinating areas of the spinal cord after immunization of mice with MOG35-55 (myelin oligodendrocyte glycoprotein) peptide. Absence of CLM-1 resulted in significantly increased nitric oxide and proinflammatory cytokine production, along with increased demyelination and worsened clinical scores, whereas T cell responses in the periphery or in the spinal cord remained unaffected. This study thus identifies CLM-1 as a negative regulator of myeloid effector cells in autoimmune demyelination.Keywords
This publication has 26 references indexed in Scilit:
- The CD300 family of molecules are evolutionarily significant regulators of leukocyte functionsTrends in Immunology, 2009
- Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic CellsAnnual Review of Immunology, 2009
- CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammationThe Journal of Experimental Medicine, 2009
- Caspase-Independent Cell Death by CD300LF (MAIR-V), an Inhibitory Immunoglobulin-Like Receptor on Myeloid CellsThe Journal of Immunology, 2008
- The IREM-1 (CD300f) Inhibitory Receptor Associates with the p85α Subunit of Phosphoinositide 3-KinaseThe Journal of Immunology, 2007
- CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAENature Immunology, 2007
- Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cellsNature Immunology, 2006
- IREM‐1 is a novel inhibitory receptor expressed by myeloid cellsEuropean Journal of Immunology, 2004
- CMRF-35-Like Molecule-1, a Novel Mouse Myeloid Receptor, Can Inhibit Osteoclast FormationThe Journal of Immunology, 2003
- Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitisJournal of Molecular Medicine, 1997